期刊文献+

Vater壶腹腺癌胰十二指肠切除后复发转移的危险因素 被引量:1

Postoperative recurrence and metastasis in patients of the ampulla of Vater adenocarcimona
原文传递
导出
摘要 目的研究Vater壶腹腺癌在胰十二指肠切除后复发转移的危险因素。方法回顾性分析1980年1月至2003年12月收治的胰十二指肠切除后存活的101例Vater壶腹腺癌的临床病理资料。结果本组患者中TNM分期Ⅰ期42例(41.6%),Ⅱ期32例(31.7%),Ⅲ期27例(26.7%)。中位随访时间为46(2~192)个月,25例(24.8%)复发转移,中位复发转移时间为20(2~93)个月。局部复发11例(10.8%),远处转移20例(19.6%),其中6例同时出现局部复发与远处转移。复发转移的25例患者与未复发转移的76例患者的肿瘤最大直径〉2cm(64%比39%,x^2=4.56,P=0.033)、淋巴结阳性率(52%比17%,x^2=11.98,P=0.001)和手术并发症发生率(51%比20%,x^2=7.50,P=0.006)之间相比差异有统计学意义。Logsitic回归分析发现,只有淋巴结转移(OR=5.14,P=0.0037)是复发转移的独立预后因素。未出现淋巴结转移患者中位无复发生存时间为49(2~192)个月,淋巴结转移患者为32(12—152)个月,两者相比差异有统计学意义(x^2=5.43,P=0.0198)。结论Vater壶腹腺癌在胰十二指肠切除后复发转移较为常见;淋巴结转移是术后复发转移的独立危险因素。 Objective To identify the prognostic factors influencing the recurrence and metastasis of adenocarcinoma of the ampulla of Vater after panreaticoduodenectomy. Methods A retrospective study was carried out on the clinical manifestation, pathological behavior and survival data in 101 patients with Vater's ampullary adenocarcinoma receiving pancreaticoduodenectomy from Jan 1980 to Dec 2003. Results According to TNM system, there were 42 cases (41.6%) of stage Ⅰ , 32 cases (31.7%) of stage Ⅱ , 27 cases (26.7%) of stage Ⅲ. During postoperative follow-up period [ median, 46 (2 - 192) months] 25 patients (24. 8% ) suffered from recurrence or/and metastasis with the median recurrence time of 20 (2 -93) months, among which there were 11(10. 8% ) cases of local recurrence and 20(19.6% ) cases of distant metastasis. The differences were statistically significant between the patients with recurrence or/and metastasis and those without in the following parameters: tumor size larger than 2 cm (64% vs, 39% , x^2 = 4. 56, P =0. 033), positive lymph node metastasis in the primary specimens (52% vs. 17% , x^2 = 11.98, P =0. 001 ) , postoperative complications ( 51% vs. 20%, x^2 = 7.50, P = 0. 006 ). Logistic regression showed only lymph node status (OR = 5.14, P = 0. 0037) was independent factors of tumor recurrence and metastasis. The median non-recurrent time in those without lymph node metastasis was 49 (2 - 192 ) months, significantly longer than the median 32 (12 -152) months in those with metastasis (x^2 = 5. 43, P =0. 0198, log-rank test). Conclusions Recurrent metastasis is the main problem in patients with ampullary adenocarcinoma after pancreaticoduodenectomy. The lymph node status is an independent prognostic factor.
出处 《中华普通外科杂志》 CSCD 北大核心 2008年第11期817-820,共4页 Chinese Journal of General Surgery
关键词 腺癌 肿瘤转移 胰十二指肠切除术 肝胰管壶腹 危险因素 Adenocarcinoma Neoplasm matastasis Panceaticoduodenectomy Ampulla of Vater Risk factors
  • 相关文献

参考文献10

  • 1Hsu HP, Shan YS, Hsieh YH, et al. Predictors of recurrence after pancreaticoduodenectomy in ampullary cancer: comparison between non-early and late recurrence. J Formos Med Assoc, 2007, 106:432- 443.
  • 2Chiche L, Alkofer B, Parienti JJ, et al. Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater. HPB, 2007,9: 140-145.
  • 3Riall TS, Cameron JL, Lillemoe KD, et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery, 2006, 140:764-772.
  • 4Gutierrez JC, Franceschi D, Koniaris LG. How many lymph nodes properly stage a periampullary malignancy? J Gastrointest Surg, 2008, 12:77-85.
  • 5Sakata J, Shirai Y, Wakai T, et al. Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma. Eur J Surg Oncol, 2007,33 : 346-351.
  • 6Bucher P, Chassot G, Durmishi Y, et al. Long-term results of surgical treatment of Vater's ampulla neoplasms. Hepatogastroenterology, 2007, 54: 1239-1242.
  • 7Brown KM, Tompkins AJ, Yong S, et al. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg, 2005, 140:529-532.
  • 8Adler DG, Qureshi W, Davila R, et al. The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc, 2006, 64 : 849-854.
  • 9Bhatia S, Miller RC, Haddock MG,et al. Adjuvant therapy for ampullary carcinomas: the Mayo clinic experience. Int J Radiat Oncol Biol Phys, 2006, 66:514-519.
  • 10Krishnan S, Rana V, Evans DB, et al. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of Vater. Int J Radiat Oncol Biol Phys, 2008,70 :pp735-743.

同被引文献10

  • 1Chareton B,Coiffic J,Linden S,et al.Diagnosis andtherapyfor ampullary tumolrs:63 cases.World J Surg,1996,20:707-712.
  • 2Klein P,Reingruber B,Kastl S,et al.Is local excision of pTl-ampullary carcinomas justitled?Eur J Surg Oneol,1996,22:366-371.
  • 3Demetriades H,Zseharakis E,Kirou I,et al.Local excision as a trelltment for tumorsl of ampulla of Vater.World J Slag Oneol,2006,4:1-6.
  • 4Greene FL,Compton CC,Fritz AG,et al.AJCC(cancer staging manual.6th ed.New York:Springer-Verlag,2002:p151-154.
  • 5Kubo H,Chijiiwa Y,AkahoshiK,et al.Pre-operative staging of ampullary tumors by endoseopic ultrasound.Br J Radiol,1999,72:443-447.
  • 6Heidecke CD,Rosenberg R,Bauer M,et al.Impact of grade of dysplasia in villous adenomas of Vater's papilla.World J Surg,2002.26:709-714.
  • 7Menegbetti AT,Safadi B,Stewart L,et al.Local resection of ampullary tumors.J Gastrointest Surg,2005,9:1300-1306.
  • 8Schoenberg MH,Treitschke F,Harada N,et al.Benigntumour of the ampulla of Vater:surgical treatment and prognosxs.Eur J Sung.1998,164:765-770.
  • 9Beger HG,Thorab FC,Liu Z,et al.Pathogenesis and treatment of neoplastic diseases of the papilla of Vater:Kauseh-Whipple procedure with lymph node diSSection in cancer of the papilla of Vater.J Hepatobiliary Panereat Surg,2004,11:232-238.
  • 10Yoon Srd,Kim MH,Kim MJ,et al.Focal early stage caltleelr in ampllary adenoma:surgery or endoscopic papillectomy?Gastrointest Endosc.2007.66:701-707.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部